Research summary, original research, 2026

Clinical Feasibility of Robotic-Assisted Endovascular Visceral Interventions

Wagenpfeil J, Kupczyk PA, Reinert M, Nadal J, Meyer C, Isaak A, et al.. Cardiovascular and interventional radiology. 2026

Read the original paper

In plain language

In 45 patients undergoing liver and prostate embolization at one German center, robotic catheter navigation from the control room was feasible in about 89% of cases and the remote operator recorded no measurable dose; in-room staff dose was not measured.

At a glance

Type of study
Original research, Prospective cohort study
Who was studied
Interventional radiologists, Patients
Size
n = 45 patients
Where
Germany
Summary based on
the full text

What it found

  • Operator dose was lower with remote robotic operation from the control room than with conventional manual procedures.

    Key figures: 0.000 mSv (IQR 0.000) vs. 0.005 mSv (IQR 0.005); p < .001

  • Robotic visceral interventions were technically successful in most cases, with two conversions to manual navigation.

    Key figures: 16/18 (88.9%; 95%-confidence interval (CI) (Wilson) 67.3-96.7%)

  • Patient procedural dose did not differ significantly between robotic and conventional procedures.

    Key figures: 107.85 Gycm2 vs. 128.00 Gycm2; p = .286

  • Procedure duration and total examination time were similar, attributed to parallel preparation of the robot.

    Key figures: 65 vs. 59 min, p = 0.711; 100 vs. 100 min, p = 0.853

  • Robotic procedures were performed remotely by a pregnant interventionalist without lead gear; staff in-room dose was not formally assessed.

Limits to keep in mind

Small, single-center, non-randomized pilot with different operators and suites for each arm; only operator dose was measured, not in-room staff dose, and manual access steps still required in-room staff.

How this summary was made

ORSIF prepared this summary with AI assistance from the full text of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.